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ABSTRACT The presence of cholesterol is critical in deﬁning a dynamic lateral structure in pulmonary surfactant membranes.
However, an excess of cholesterol has been associated with impaired surface activity of surfactant. It has also been reported that
surfactant protein SP-C interacts with cholesterol in lipid/protein interfacial ﬁlms. In this study, we analyzed the effect of SP-C on
the thermodynamic properties of phospholipid membranes containing cholesterol, and the ability of lipid/protein complexes
containing cholesterol to form and respread interfacial ﬁlms capable of producing very low surface tensions upon repetitive
compression-expansion cycling. SP-C modulates the effect of cholesterol to reduce the enthalpy associated with the gel-to-
liquid-crystalline melting transition in dipalmitoylphosphatidylcholine (DPPC) bilayers, as analyzed by differential scanning calo-
rimetry. The presence of SP-C affects more subtly the effects of cholesterol on the thermotropic properties of ternary membranes,
mimicking more closely the lipid composition of native surfactant, where SP-C facilitates the miscibility of the sterol. Incorporation
of 1% or 2% SP-C (protein/phospholipid by weight) promotes almost instantaneous adsorption of suspensions of DPPC/palmi-
toyloleoylphospatidylcholine (POPC)/palmitoyloleoyl-phosphatidylglycerol (POPG) (50:25:15, w/w/w) into the air-liquid interface
of a captive bubble, in both the absence and presence of cholesterol. However, cholesterol impairs the ability of SP-C-containing
ﬁlms to achieve very low surface tensions in bubbles subjected to compression-expansion cycling. Cholesterol also substantially
impairs the ability of DPPC/POPC/POPG ﬁlms containing 1% surfactant protein SP-B to mimic the interfacial behavior of native
surfactant ﬁlms, which are characterized by very low minimum surface tensions with only limited area change during compres-
sion and practically no compression-expansion hysteresis. However, the simultaneous presence of 2% SP-C practically restores
the compression-expansion dynamics of cholesterol- and SP-B-containing ﬁlms to the efﬁcient behavior shown in the absence of
cholesterol. This suggests that cooperation between the two proteins is required for lipid-protein ﬁlms containing cholesterol to
achieve optimal performance under physiologically relevant compression-expansion dynamics.doi: 10.1016/j.bpj.2009.08.045INTRODUCTION
Pulmonary surfactant is a complex mixture of lipids and
proteins whose main function is to reduce the surface tension
at the alveolar air-liquid interface of lungs to facilitate the
work of breathing. A lack, deficiency, or inactivation of
this essential material can cause severe respiratory disorders
such as neonatal respiratory distress syndrome (NRDS) or
acute respiratory distress syndrome (ARDS) (1). It is com-
posed of ~90% lipids (mainly phospholipids) and 8–10%
proteins; ~80% of surfactant by mass is composed of
phosphatidylcholine (PC), half of which is dipalmitoylphos-
phatidylcholine (DPPC) (2). The acidic phospholipids phos-
phatidylglycerol (PG) and phosphatidylinositol (PI) account
for 8–15% of the total surfactant phospholipid pool. Choles-
terol is the major neutral lipid, accounting for up to 8–10% of
surfactant by weight. The phospholipid fraction within lung
surfactant, and particularly DPPC, is essentially responsible
for the maximal surface tension reduction upon compression.
However, the presence of proteins, particularly SP-B and
SP-C, is absolutely required for interfacial adsorption, film
stability, and respreading capacities (3,4).
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0006-3495/09/11/2736/10 $2.00SP-B and SP-C are small hydrophobic polypeptides that
account for no more than 1–1.5% of total surfactant weight
but play critical roles in the formation and stabilization of
pulmonary surfactant films (5). In contrast to SP-B, surfac-
tant protein SP-C is not absolutely required for survival.
However, targeted deletion of the SP-C gene (SP-C/) in
mice leads to the development of severe progressive pneu-
monitis, depending on the genetic background (6,7). Exper-
imental data suggest that SP-C would be required to maintain
the association of surfactant complexes (the reservoir) with
the interfacial film at the most compressed states, i.e., those
reached at the end of expiration (3). The SP-C-promoted
attachment would then facilitate the reinsertion of surface-
active molecules from the reservoirs, with the probable crit-
ical participation of SP-B, during reexpansion (3,8–11).
Some authors have suggested the existence of SP-C/cho-
lesterol complexes in membranes (10,12); however, both
direct evidence and a model explaining the role of SP-C/
cholesterol interactions in surfactant function are lacking. It
has been proposed that cholesterol could contribute to
prevent SP-C from aggregating, leading to a better misci-
bility of the protein into monolayers (12). On the other
hand, a previous study suggested that concomitant changes
in the concentration of cholesterol and SP-C may occur in
SP-C and Cholesterol in Surfactant 2737the surfactant of heterothermic animals (13), and that the
roles of these two molecules in surfactant may therefore be
connected.
Our main goal in this study was thus to gain further knowl-
edge about the occurrence and potential significance of inter-
actions between cholesterol and SP-C. Herein, we report the
thermodynamic characterization of model membranes con-
taining cholesterol and SP-C and a functional study of these
membranes. The results are discussed in terms of a combined
role of both components in lung surfactant and the possible
modulation of the effect of cholesterol in surfactant by SP-C.
EXPERIMENTAL PROCEDURES
Materials
DPPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3[phospho-rac-(1-glycerol)] (POPG), and
cholesterol were obtained from Avanti Polar Lipids (Alabaster, AL).
Chloroform and methanol solvents, HPLC grade, were obtained from Schar-
lau (Barcelona, Spain). Native surfactant was purified from porcine lungs as
described previously (14). Surfactant proteins SP-B and SP-C were isolated
from minced porcine lungs as described elsewhere (15). Quantitation of
proteins was achieved by amino acid analyses.
Reconstitution of lipid and lipid/protein samples
The standard lipid mixture used in this study as a surfactant model contained
DPPC/POPC/POPG (50:25:15, w/w/w). This mixture simulates the pro-
portion of saturated/unsaturated and zwitterionic/anionic phospholipids in
surfactant. The mixture was modified by adding different proportions of
cholesterol and surfactant proteins. Multilamellar suspensions were prepared
by mixing protein and lipids in chloroform/methanol 2:1. Samples were
dried overnight under vacuum and resuspended in 5 mM Tris/HCl buffer
(pH 7) containing 150 mM NaCl, with incubation for 1 h at 51C.
Differential scanning calorimetry
For differential scanning calorimetry (DSC), the excess heat capacity (Cp) of
lipid or lipid/protein samples was measured in a VP-DSC differential scan-
ning microcalorimeter (MicroCal, Northampton, MA). Two membrane
models were used in these experiments. The first set of experiments
measuredDPPCorDPPC/SP-Cmultilamellar suspensions (50:1 or 10:1,w/w)
at a final phospholipid concentration of 0.5 mg/mL. Other experiments
were performed using DPPC/POPC/POPG or DPPC/POPC/POPG/SP-C
multilamellar suspensions (50:25:15 or 50:25:15:2, w/w) at a phospholipid
concentration of 2 mg/mL. The vesicles contained 0%, 3%, 5%, 10%, or
20% cholesterol for pure DPPC membranes, and 0%, 2%, or 5% choles-
terol/total phospholipid (w/w) for the ternary membranes. Samples and
reference cells were heated from 25C to 85C at 0.5C/min. The calori-
metric data were analyzed using ORIGIN software (MicroCal) after baseline
correction and concentration normalization. The molar enthalpy of the phase
transition, DH, was obtained from the area under the main DSC peak. The
temperature of the transition, Tm, is reported as the temperature at which
Cp is maximal.
Captive bubble surfactometry
We determined the surface activity of the model surfactant mixtures using
a captive bubble surfactometer (CBS) (16), which allowed us to monitor
the surface tension (g) of surfactant films subjected to compression-expan-
sion dynamics. We used a modification of a previously described procedure
(17), which included the addition of sucrose (10% w/w) to the buffer in thechamber to increase its density so that the surfactant suspensions would float
and remain in contact with the bubble upon injection. The temperature was
maintained between 36.8C and 37.1C. To start each experiment, ~250 nL
of lipid or lipid/protein suspension (10 mg/mL) were deposited close to the
air-buffer interface of a small air bubble (~50 mL) by means of a thin capil-
lary. The high density of the sucrose-containing buffer prevents dilution
within the whole chamber of the small volume of aqueous surfactant suspen-
sion that is introduced, which then forms a thin layer of liquid sourrounding
the bubble, from which the surfactant complexes can adsorb into the inter-
face. In our opinion, this setup mimics reasonably well the actual geometry
of the thin layer of concentrated surfactant at the alveolar surface in the
lungs. The bubble was imaged with a video camera (TM 7 CN; Pulnix
America Inc., Sunnyvale, CA) and recorded for later analysis. A 5 min
period followed the introduction of surfactant suspensions into the chamber,
during which the change in g was monitored to follow film formation. The
chamber was then sealed and the bubble was rapidly (1 s) expanded to
a volume of 0.15 mL. Quasistatic cycling commenced 5 min after the bubble
was expanded (to permit for postexpansion adsorption and film equilibra-
tion). The bubble size was first reduced and then enlarged in several steps,
each of which included a change in volume and 5 s of delay. There was
an intercycle delay of 0.5 min between each of the four quasistatic cycles,
and a further 2 min delay between the quasistatic and dynamic cycles. In
the latter, the bubble size was continuously varied for 20 cycles at a rate
of 20 cycles/min. The bubble volume and area and surface tension were
calculated from examination of the shape of the bubble using an axisym-
metric model (18). We performed at least three independent experiments
for each surfactant suspension, using at least two different batches of purified
protein, and obtained qualitatively comparable results. The figures represent
illustrative example experiments for each surfactant model.
RESULTS
We investigated the thermotropic behavior of DPPC bilayers
in the absence or presence of SP-C and cholesterol to analyze
the nature of the interaction between SP-C and lipids from
a thermodynamic point of view. Fig. 1 shows the effect of
the presence of increasing proportions of cholesterol on the
thermotropic behavior of DPPC membranes, in either the
absence or presence of SP-C 2% or 10% (protein/lipid,
w/w). The phase transition of pure DPPC bilayers is abrupt,
as demonstrated by the peak sharpness. The effects of
a gradual increase of the concentration of cholesterol include
the disappearance of the Lb-Pb0 pretransition peak, which
occurs in DPPC at ~35C; the broadening of the main tran-
sition at 41C; and a remarkable reduction of the transition
enthalpy, as revealed by a decrease in the area under the
main calorimetric peak. In the presence of SP-C, the broad-
ening of the transition is even more noticeable, even though
the effects of both membrane components are not additive, as
shown in Fig. 2 and in Table S1 of the Supporting Material.
The combined effect of cholesterol and the protein
requires further analysis. Fig. 2A plots the enthalpy of the
phase transition, calculated per mol of DPPC, as a function
of the DPPC/cholesterol molar ratio, in the presence and
absence of SP-C 2% or 10% (protein to phospholipid,
w/w). The presence of cholesterol progressively reduces
the enthalpy associated with transition in a linear fashion.
In the presence of SP-C, the interaction follows the same
linear trend at high proportions of cholesterol. However, atBiophysical Journal 97(10) 2736–2745
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to significantly reduce the enthalpy associated with phase
transition in the lipid/protein membranes. The amount of
cholesterol above which the enthalpy of the lipid complexes
is again reduced depends on the proportion of SP-C present.
Cholesterol proportions higher than 10% (mol/mol) with
respect to phospholipid are required to reduce the calori-
metric enthalpy in membranes containing 2% SP-C, whereas
only proportions of cholesterol higher than 20% substan-
tially reduce the enthalpy of membranes containing 10%
SP-C. The concentration of cholesterol needed to signifi-
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FIGURE 1 Thermotropic behavior of DPPC bilayers in the presence of
cholesterol and SP-C. DSC thermograms of DPPC multilamellar suspen-
sions were obtained in the absence (left) or presence of 2% (center) or
10% (right) protein/phospholipid by weight of porcine SP-C containing
the indicated proportions of cholesterol (w/w with respect to phospholipid).Biophysical Journal 97(10) 2736–2745cantly affect the thermodynamics of the system is thus higher
in the presence of a higher concentration of protein, which
may indicate a direct interaction between cholesterol and
SP-C. The additivity of the effects of cholesterol and protein
is further analyzed in the contour plot that shows the propor-
tions of cholesterol and SP-C that produce equivalent
enthalpy values once they are incorporated into the DPPC
membranes (Fig. 2B). If the combined action of cholesterol
and SP-C is merely additive, the lines in this plot should
be diagonal lines connecting the two axes. If the combined
effect is not additive (e.g., one of the components buffers
the effect of the other), the lines should be parallel to one
of the axes. Fig. 2B illustrates how the presence of increasing
amounts of cholesterol and DPPC produces nonadditive
effects, consistent with partial counteraction between SP-C
and cholesterol with respect to their mutual effect on the tran-
sition enthalpy.
We also characterized the thermotropic behavior of
ternary DPPC/POPC/POPG bilayers in the absence or pres-
ence of SP-C and/or cholesterol. These bilayers mimic the
ratio of zwitterionic/anionic and saturated/unsaturated phos-
pholipids found in native surfactant. The effect of increasing
proportions of cholesterol on DPPC/POPC/POPG mem-
branes in the absence or presence of SP-C 2% (protein/lipid,
w/w) is shown in Fig. S1. Remarkably, the thermograms of
membranes containing 5% cholesterol with respect to phos-
pholipid (w/w) are very similar to those of native porcine
surfactant (19). The thermotropic transition that occurs in
natural surfactant membranes has been interpreted as
a liquid-ordered to liquid-disordered phase transition, with
a reduced enthalpy compared to that of a typical gel-to-liquid
crystalline transition (19). The effects of increasing propor-
tions of cholesterol on the ternary membranes are not as
dramatic as in pure DPPC membranes because the transition
of ternary membranes is already broadened in the absence of
cholesterol, but they include a further broadening of the main
transition, occurring now around 30C, and a reduction of
the transition enthalpy (see Table S2). In the presence of
SP-C, the transition is even more broadened, but, as occurs
in DPPC membranes, the effects of SP-C and cholesterol0
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B FIGURE 2 Dependence of the phase transition enthalpy
of DPPC bilayers on cholesterol content in the absence or
presence of SP-C. (A) The enthalpy associated with the
main phase transition of DPPC bilayers, determined from
the area under the main calorimetric peak in thermograms
of Fig. 1, is plotted against the DPPC/cholesterol molar
ratio in the absence (diamonds) or presence of SP-C 2%
(squares) or 10% (triangles) by weight with respect to
phospholipids. (B) Contour plot of values of equivalent
enthalpy determined from the calorimetric behavior of
DPPC bilayers containing variable amounts of cholesterol
and/or SP-C. Lines connect the combined proportions of
cholesterol and SP-C that produce the similar enthalpy
value indicated in each line once they are incorporated
into DPPC suspensions.
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FIGURE 3 Functional behavior of native porcine surfac-
tant in a CBS. (A) Time course for initial () and postexpan-
sion (:) adsorption of native surfactant (250 nL, 10mg/mL
phospholipid) deposited at the captive bubble interface.
(B) Cycles 1 (A), 2 (-), 3 (:), and 4 () are represented.
(C) Compression-expansion isotherms under dynamic
cycling. Cycles 1 (A), 10 (-), and 20 (:) are represented.do not seem to be additive. Of interest, the presence of SP-C
seems to facilitate the homogeneous mixing of cholesterol.
In the absence of the protein, introduction of 2% cholesterol
yields a complex thermogram, including a secondary peak at
~22C overlapping with the main transition, which exhibits
its maximum heat capacity at 29.5C. This is likely an indi-
cation of the coexistence of two segregated membrane
regions with presumably different cholesterol contents. The
secondary component practically disappears in the presence
of SP-C, indicating that cholesterol distributes more homo-
geneously in SP-C-containing bilayers.
To characterize a possible modulation of the surfactant
function by the interaction between cholesterol and SP-C,
we evaluated the activity of samples containing different
concentrations of cholesterol and SP-C in a CBS. As a refer-
ence, Fig. 3 shows the behavior of native pulmonary surfac-
tant, as purified from porcine lungs. Native surfactant
adsorbed to the interface extraordinarily fast (Fig. 3A), pro-
ducing equilibrium surface tensions close to 22 mN/m within
the first minute. Compression of such adsorbed surfactant
films under quasistatic conditions produced surface tensions
lower than 1 mN/m with only a 20% area reduction, whereas
surface tension hardly increased above 30 mN/m upon
bubble expansion (Fig. 3B). Furthermore, the compression
and expansion moieties of the cycling isotherms showed
almost no hysteresis, indicative of the extraordinary stability
of the native surfactant film during cycling dynamics. This
remarkable behavior is even more pronounced when the
films are subjected to rapid, physiological-like compres-
sion-expansion dynamics at 20 cycles/min (Fig. 3C). The
ability of surfactant to produce very low surface tensions
with only limited area change during compression, the rela-
tively low maximal surface tensions upon expansion, and the
little hysteresis are considered essential requirements of
a functional lung surfactant.
Fig. 4 shows the time course for the reduction of surface
tension upon adsorption of model membranes consisting of
the mixture DPPC/POPC/POPG (50:25:15, w/w/w), in the
absence or presence of cholesterol 5% or 10% (w/w) and
SP-C 1% or 2% (protein/phospholipid, w/w). In the absence
of protein, adsorption of pure lipid samples was limited,which reduced surface tension to values of ~45 mN/m, and
further impaired in the presence of cholesterol. Expansion
of these films resulted in almost no further change in surface
tension. In contrast, all the samples containing SP-C reduced
surface tension to values of ~22 mN/m. The minimum
surface tensions reached were lowest in the absence of
cholesterol and in the presence of the highest concentration
of protein. Film expansion, in the presence of SP-C, led to
the adsorption of additional surfactant material associated
with the surface. Lower decreases in surface tension
occurred at cholesterol 5%, reflecting a lower efficiency in
the insertion of new material from reservoirs. However,
increasing the concentration of cholesterol from 5% to
10% produced a slight improvement in the surface tension
reduction, possibly due to a direct effect of the sterol on
the membrane fluidity or the segregation of membrane
phases (20).
Figs. 5 and 6 respectively show the quasistatic and
dynamic compression-expansion isotherms of films formed
from suspensions of DPPC/POPC/POPG (50:25:15, w/w/w)
containing SP-C 1% or 2%, in the absence or in the presence
of 5% or 10% cholesterol. In the presence of 1% SP-C, the
films were not able to reach sufficiently low minimum
surface tensions under quasistatic compression, in either
the presence or absence of cholesterol, and the presence of
increasing proportions of cholesterol produced progressively
higher minimal tensions. All the isotherms presented con-
spicuous plateaus at ~22–23 mN/m, which were previously
interpreted as the result of compression-driven, three-dimen-
sional transitions (13). In the absence of cholesterol and in
the presence of 1% SP-C, quasistatic compression of
DPPC/POPC/POPG films allowed progression to minimum
tensions on the order of 13–15 mN/m, which are still higher
than those required to properly stabilize the interface.
Maximal surface tensions, reached at the end of expansion,
were also high, suggesting that the excluded material is not
respreading into the interface efficiently. Inclusion of pro-
gressively higher proportions of cholesterol further impairs
the ability of the films to progress toward very low surface
tensions. Of interest, increasing proportions of cholesterol
also reduce the maximal surface tensions achieved alongBiophysical Journal 97(10) 2736–2745
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In the absence of cholesterol and in the presence of SP-C
2%, the films were able to reach close to zero surface tension
upon compression. However, in the presence of cholesterol
5% or 10%, the films only reduced surface tensions to 5
and 20 mN/m, respectively, under quasistatic compression.
When subjected to dynamic compression-expansion
cycling, all the films containing 1% or 2% SP-C were able
to reach very low tensions, in either the absence or presence
of cholesterol. However, the changes in relative surface area
FIGURE 4 Effect of SP-C and cholesterol on the interfacial adsorption of
phospholipids at a bubble air-liquid interface. (Left panels) Surface tension
versus time adsorption isotherms were obtained after spreading 0.5 mL of
a suspension 10 mg/mL of the mixture DPPC/POPC/POPG (50:25:15:1,
w/w/w) in the absence (upper panels) or presence of SP-C 1 or 2% (w/w)
(central and lower panels, respectively), at the surface of a 50 mL air bubble
formed into a subphase of 5 mM Tris, 150 mM NaCl, pH 7.0, containing
sucrose (10% w/w). (Right panels) Interfacial adsorption leading to
a decrease in surface tension was monitored upon expansion of the bubble
from 0.05 to a volume of 0.15 mL. The samples assayed contained 0%
(), 5% (B), or 10% (;) cholesterol/phospholipid by weight.Biophysical Journal 97(10) 2736–2745that were required were considerable (see Table S3) and
showed large compression-expansion hysteresis, reflecting
the low stability of compressed phases. A further increase
in the concentration of SP-C, up to 3% or 5% by weight
with respect to phospholipids, did not reestablish the original
behavior of these films in the absence of cholesterol (see
Fig. S2).
We repeated our experiments in the presence of 1% SP-B
purified from porcine lungs. Membranes containing SP-B or
both SP-B and SP-C were functionally tested in the CBS in
the absence or presence of cholesterol 5%. Fig. 7 shows the
adsorption kinetics from SP-B-containing membranes during
the initial or postexpansion adsorption. In the absence of
cholesterol, SP-B promoted a very rapid adsorption of lipids
into the interface, to equilibrium tension values of
~22–23 mN/m, with or without SP-C. The introduction of
cholesterol significantly impaired the ability of lipid-protein
complexes containing SP-B to rapidly achieve low surface
tensions. The simultaneous presence of SP-C, however,
substantially restored the ability of cholesterol- and SP-B-
containing films to produce tensions below 30 mN/m. The
quasistatic and dynamic compression-expansion isotherms
of the SP-B/lipid films in the absence or presence of SP-C
and cholesterol are shown in Figs. 8 and 9, respectively.
The performance of these films in the absence of SP-C and
cholesterol was surprisingly similar to that of whole native
surfactant. Minimum surface tensions were reached very
efficiently, with only an ~20% area change, and the system
expanded to maximal tensions lower than 30 mN/m with
almost no hysteresis. The presence of cholesterol dramati-
cally impaired the performance of SP-B-containing films
under both quasistatic and dynamic compression-expansion
cycling. Compressions on the order of 60% of the initial
area were required to reach the minimal tension in these
films, which was higher than the minimal tension reached
in the absence of cholesterol. Cholesterol also produced
much higher maximal surface tensions and introduced a
considerable hysteresis into the compression-expansion
cycles. Given these results, one might conclude that the pres-
ence of cholesterol makes the films much less efficient in
terms of reaching low surface tensions during compression.
However, the simultaneous inclusion of 2% SP-C prevented
most of the deleterious effects caused by 5% cholesterol in
the compression-expansion dynamics of SP-B containing
films. Films containing both SP-B and SP-C and cholesterol
were able to produce under compression as low surface
tension as films containing SP-B in the absence of cho-
lesterol, with similarly limited compression and reduced
hysteresis.
DISCUSSION
Even though cholesterol accounts for the major fraction of
neutral lipids in lung surfactant, its role in this material
remains unknown. Cholesterol has been reported to
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FIGURE 5 Effect of SP-C and cholesterol on the quasi-
static compression-expansion isotherms of phospholipid
films in a CBS. Quasistatic compression-expansion iso-
therms of films adsorbed from DPPC/POPC/POPG
(50:25:15, w/w/w) suspensions containing 1% (upper
panels) or 2% (lower panels) SP-C and 0% (left), 5%
(central), or 10% (right) cholesterol/phospholipid by
weight. Plotted are isotherms obtained from the first (A),
second (-), third (:), and fourth () sequential compres-
sion and expansion cycles.modulate the fluidity of lipid mono- and bilayers (10), and
increase their stability and impermeability to water (21,22).
Several studies have reported that the ability of different
surfactant models to reach very low surface tensions is mark-
edly impaired in the presence of cholesterol (12,23,24).Furthermore, the impaired surface activity of surfactant
obtained from patients of ARDS has been attributed in part
to an elevated content of cholesterol (25).
The physiological relevance of cholesterol in maintaining
the structure of pulmonary surfactant membranes was provedCholesterol (w/w)
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FIGURE 6 Effect of SP-C and cholesterol on the
dynamic compression-expansion isotherms of phospho-
lipid films in a CBS. Dynamic compression-expansion
isotherms, obtained at 20 cycles/min, of films adsorbed
from DPPC/POPC/POPG (50:25:15, w/w/w) suspensions
containing 1% (upper panels) or 2% (lower panels) SP-C
and 0% (left), 5% (central), or 10% (right) cholesterol/
phospholipid by weight. Plotted are isotherms obtained
from the first (A), 10th (-), and 20th (:) sequential
compression and expansion cycles.Biophysical Journal 97(10) 2736–2745
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istence of fluid-ordered and fluid-disordered-like phases
promoted by cholesterol at physiological temperatures.
This structure was dramatically affected by the extraction
of cholesterol. The presence of cholesterol also produces
a dynamic effect on the order, mobility, and lateral diffusion
of surfactant phospholipids (19). Cholesterol has also been
shown to introduce a dynamic contribution in the structure
of surfactant films. Native surfactant films or films formed
from the whole surfactant hydrophobic fraction, including
cholesterol, exhibit complex compression-driven lateral
transitions, including segregation and remixing of phases,
that are profoundly altered when cholesterol is removed
FIGURE 7 Effect of SP-C and cholesterol on the interfacial adsorption of
phospholipid suspensions containing SP-B. (Left panel) The surface tension
versus time adsorption isotherms was obtained after spreading 0.5 mL of a
suspension of 10 mg/mL of the mixture DPPC/POPC/POPG (50:25:15:1,
w/w/w) containing 1% SP-B (protein/phospholipid by weight) in the
absence (closed symbols) or presence (open symbols) of 5% cholesterol/
phospholipid (w/w), in the absence (circles) or presence (triangles) of 2%
SP-C (protein/phospholipid, w/w; central and lower panels, respectively),
and at the surface of a 50 mL air bubble formed into a subphase 5 mM
Tris, 150 mM NaCl, pH 7.0, containing sucrose (10% w/w). (Right panel)
Interfacial adsorption was further monitored in the same bubbles upon
expansion of the bubble from 0.05 to a volume of 0.15 mL.Biophysical Journal 97(10) 2736–2745(26–28). Recent studies suggest that physiological levels of
cholesterol (up to 10% by weight with respect to phospho-
lipids) may modulate surfactant function (29–31). The
beneficial function of physiological cholesterol levels in
surfactant has been clearly established for heterothermic
animals, in which the concentration of cholesterol varies
rapidly in response to body temperature changes (32). The
experimental data presented here strongly suggest an interac-
tion between cholesterol-enriched phases and SP-C, and
a functional role of this interaction in modulating the proper-
ties of the surfactant membranes and films. We cannot
unequivocally establish at this point whether there is a direct
molecular interaction between SP-C and cholesterol or
whether SP-C has a preferential interaction with choles-
terol-containing membrane phases, in which other lipids
such as DPPC and PG may also play a role.
Model membranes containing DPPC/POPC/POPG and
SP-C reached low minimum surface tensions but were not
able to maintain a stable configuration, as evidenced by the
large hysteresis and the failure to lower the maximum
surface tension. The presence of cholesterol within these
membranes lowered the efficiency in the insertion of new
material from reservoirs, and also prevented the films
from reaching minimum surface tensions along subsequent
compression-expansion cycles, presumably due to the failure
of the compressed films to sustain low tensions without
deformation. The mechanical stability of surfactant films
subjected to compression is usually associated with the seg-
regation in the surfactant layers of DPPC-enriched domains,
which are in a gel-like state at physiological temperatures.
The presence of cholesterol increases the intrinsic fluidity
of these ordered domains, which are then in a liquid-ordered
state, with a smaller value of associated melting enthalpy and
a lower mechanical stability.
The paradoxical effect of cholesterol on the interfacial
performance of pulmonary surfactant films was previously
investigated with the use of bovine lipid extract surfactant
(BLES), a clinical surfactant produced by depletion of neu-
tral lipids from organic extracts of bovine bronchoalveolarRelative Surface Area
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FIGURE 8 Effect of SP-C and cholesterol on the quasi-
static compression-expansion isotherms of phospholipid
films containing SP-B. Quasistatic compression-expansion
isotherms of films adsorbed from DPPC/POPC/POPG
(50:25:15, w/w/w) suspensions containing 1% SP-B in
the absence of cholesterol and SP-C (left panel), in the
absence of SP-C but in the presence of 5% cholesterol/
phospholipid by weight (central panel), or in the presence
of both cholesterol 5% and SP-C 2% (protein/phospholipid
by weight). Plotted are isotherms obtained from the first
(A), second (-), third (:), and fourth () sequential
compression and expansion cycles.
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FIGURE 9 Effect of SP-C and cholesterol on the
dynamic compression-expansion isotherms of phospho-
lipid films containing SP-B. Dynamic compression-expan-
sion isotherms, obtained at 20 cycles/min, of films adsorbed
from DPPC/POPC/POPG (50:25:15, w/w/w) suspensions
containing 1% SP-B in the absence of cholesterol and
SP-C (left panel), in the absence of SP-C but in the presence
of 5% cholesterol/phospholipid by weight (central panel),
or in the presence of both cholesterol 5% and SP-C 2%
(protein/phospholipid by weight). Plotted are isotherms
obtained from the first (A), 10th (-), and 20th (:)
sequential compression and expansion cycles.lavages (30). BLES can accept up to 10% of cholesterol
while maintaining the ability to reach very low surface
tensions. Inclusion of cholesterol proportions on the order
of 20%, however, significantly impaired the performance
of BLES films. Our data suggest that the presence of SP-C
in BLES extracts could be responsible for preventing the
deleterious effects of cholesterol. An exacerbated amount
of cholesterol, however, might not be properly buffered by
the limited amount of SP-C and could progressively intro-
duce a destabilizing effect.
We have demonstrated that a simple lipid mixture
mimicking the actual proportions of DPPC and anionic phos-
pholipid species in surfactant is able to reproduce the inter-
facial behavior of native surfactant as long as SP-B is
present. If physiological proportions of cholesterol are also
introduced, an efficient performance is observed only in
the simultaneous presence of physiological-like SP-C pro-
portions. Our calorimetric data suggest that this beneficial
action of SP-C does not proceed through protein-promoted
segregation of cholesterol from the surface-active lipid
phases, because there is no reversion of the effect of choles-
terol on the thermotropic properties of membranes in the
presence of the protein. Rather, we propose that the interac-
tion of SP-C and/or attached SP-C-containing membranes
with cholesterol-enriched phases improves their mechanical
performance without necessarily altering the lateral distribu-
tion of lipid species. Cholesterol and SP-C could therefore
cooperate to provide surfactant with relatively dynamic
properties without the caveat of losing mechanical stability
at the highly compressed states. In a previous study, Gunase-
kara et al. (30) were able to partly restore the proper perfor-
mance of BLES containing 20% cholesterol by incorporating
additional amounts of DPPC. This finding indicates that it is
probably the excessively fluid/dynamic character of choles-
terol-containing surfactant phases that prevents them from
reaching stable compressed states. Further addition of
DPPC could shift the biophysical properties of certain
regions of the films from a rather fluid liquid-ordered organi-
zation into a less fluid, gel-like type of organization that ismechanically more stable. However, restoration of the films’
stability by the addition of higher proportions of DPPC
would be achieved at the cost of a substantial decrease in
dynamics and a marked impairment of the rheological
properties of lipid/protein suspensions. This is a major
problem in the context of the design of efficient clinical
surfactants. In most cases, the surfactants currently used in
respiratory medicine have an altered composition, particu-
larly with respect to the content of SP-B and SP-C (33,34).
For proper performance, these preparations require supple-
mentation with additional amounts of DPPC and/or palmitic
acid. We propose that the requirement of these spurious
lipids is related to an inappropriate balance of lipid and
protein species. As an undesired consequence, these clinical
surfactants have higher viscosities than native surfactant,
which may impair their ability to distribute efficiently
toward the distal airways (35). In the presence of adequate
proportions of SP-C, a surfactant containing limited amounts
of DPPC and cholesterol could still sustain the lowest surface
tensions at maximal compression while preserving a highly
dynamic character. Our results provide additional support
for the conclusion recently reached by Almlen et al. (36),
that both SP-B and SP-C are required for optimal function.
It is known that cholesterol increases the fluidity of
ordered phases of membranes enriched in saturated phospho-
lipid species. This increase in fluidity would have a function-
ally contradictory effect on lung surfactant performance.
Beneficially, it could favor structural transitions that facili-
tate the formation of surfactant surface reservoirs or accel-
erate respreading of compressed structures. In contrast, it
would decrease the stability of the most compressed films.
Although SP-B is the essential protein that permits surfactant
to reach the lowest tensions, an association between SP-C
and SP-C-containing membranes and relatively fluid
DPPC/cholesterol-enriched domains could help improve
the mechanical stability of surfactants and impede their
out-of-plane relaxation at the end of expiration. This model
would justify the intrinsic instability of surfactant from
SP-C knockout mice, which may contribute to their chronicBiophysical Journal 97(10) 2736–2745
2744 Go´mez-Gil et al.respiratory pathologies (6,7). It is conceivable that the levels
of SP-C and cholesterol in surfactant are coordinated in
response to different physiological requirements by molec-
ular mechanisms as yet unknown, as was previously pointed
out in a study of heterothermic animals (17).
In conclusion, this work provides additional evidence of
the existence of an interaction between cholesterol-enriched
phases and SP-C, and confirms that physiological concentra-
tions of cholesterol do not have any detrimental effect on
lung surfactant with a proper lipid and protein composition.
In the light of these results, it is clear that the inclusion of
a proper and balanced proportion of cholesterol, in conjunc-
tion with the appropriate amounts of SP-C, should be con-
sidered in the future development of optimized clinical
surfactants.
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